![Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers | SpringerLink Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00330-020-07598-8/MediaObjects/330_2020_7598_Fig2_HTML.png)
Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers | SpringerLink
![Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology | npj Precision Oncology Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology | npj Precision Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41698-021-00194-z/MediaObjects/41698_2021_194_Fig1_HTML.png)
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology | npj Precision Oncology
![Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects](https://onlinelibrary.wiley.com/cms/asset/a05fc1b4-ede0-487a-8d48-0e3654724219/ejhf266-fig-0001-m.jpg)
Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects
![Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men - eClinicalMedicine Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4c470ca7-4788-4aae-8717-8e0a48b81b58/gr1_lrg.jpg)
Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men - eClinicalMedicine
![Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study - ScienceDirect Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870318302801-gr4.jpg)